Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States.
about
Interferon for anogenital warts in non-immunocompromised adultsDistribution of genital wart human papillomavirus genotypes in China: a multi-center study.Incidence of anogenital warts in Germany: a population-based cohort study.Impact of genital warts on health related quality of life in men and women in mainland China: a multicenter hospital-based cross-sectional study.Human papillomavirus-related psychosocial impact of patients with genital warts in China: a hospital-based cross-sectional studySystematic review of the incidence and prevalence of genital warts.Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men.Incidence and human papillomavirus (HPV) type distribution of genital warts in a multinational cohort of men: the HPV in men study.Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort studyRisk factors for incident condyloma in a multinational cohort of men: the HIM study.Evaluation of safety and immunogenicity of a quadrivalent human papillomavirus vaccine in healthy females between 9 and 26 years of age in Sub-Saharan AfricaGenital HPV infection and related lesions in menKnowledge of human papillomavirus: differences by self-reported treatment for genital warts and sociodemographic characteristics.A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.Immunotherapy of HPV infection-caused genital warts using low dose cyclophosphamide.Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV).Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine in Latin American women.Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability.[Conservative treatment of anogenital HPV infections].The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries.Prevalence of anogenital warts among participants in private health plans in the United States, 2003-2010: potential impact of human papillomavirus vaccination.
P2860
Q24240816-E3A5EEE8-AAE8-4AD2-B545-81CB0E3F694CQ33777098-DAA2C604-7B0A-4579-A79F-293AD1A796BFQ33779542-94D6CFA1-140A-4981-A130-24775E7B5667Q34180616-4E9C3D21-4E95-425E-9430-EE0987A2F0D2Q34468870-44D8D6C8-A24A-4294-B334-658796814CFAQ34561142-267068D9-BDA4-487F-8B8C-F0B885814741Q34801294-197FD0EC-CEF0-4E0D-9409-03DC1E4791C1Q35532844-78C08549-34CA-4AE0-8296-3C4BCE29683FQ35596225-AD0542E9-CE7C-4223-82A3-56FB20F73629Q35741949-6BA4A6A6-4643-458A-B450-BE342FD7CEB0Q35887646-177B729C-D8C2-4319-86B9-FD5FD603791BQ36389950-070C92BA-D285-4CB6-A4EA-425BF08E14BEQ37401797-4C1DB4A1-3546-457E-96BD-55ADB52EEE95Q38006991-CFF3DAD2-1A12-48A8-B8D2-C0007E269ECBQ38211240-6E17648D-24B3-44DF-B453-E5C2A92A61DBQ43462309-96AC3187-1A78-4160-8050-1C55AC995857Q45399287-21FC1390-5E5D-4A27-8A4E-7FF3F91B6364Q47364266-2BA9FF12-7A86-4887-BB0F-0C34BCBAC633Q50529382-2ADF244E-02BD-42A0-983D-147A3597B3EBQ51727827-EF35203D-7AF9-4310-B421-1284FB207742Q51872328-23305D59-D824-483E-8692-9834E96BEDCB
P2860
Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Rate and predictors of new gen ...... patients in the United States.
@ast
Rate and predictors of new gen ...... patients in the United States.
@en
type
label
Rate and predictors of new gen ...... patients in the United States.
@ast
Rate and predictors of new gen ...... patients in the United States.
@en
prefLabel
Rate and predictors of new gen ...... patients in the United States.
@ast
Rate and predictors of new gen ...... patients in the United States.
@en
P2093
P1476
Rate and predictors of new gen ...... patients in the United States.
@en
P2093
Jeanne M Pimenta
Jill E Koshiol
Samantha A Laurent
P304
P356
10.1097/01.OLQ.0000145851.76025.AD
P577
2004-12-01T00:00:00Z